| Analgesic effects of the GIRK activator, VU0466551, alone and in combination with morphine in acute and persistent pain models KK Abney, M Bubser, Y Du, KA Kozek, TM Bridges, CW Lindsley, ... ACS chemical neuroscience 10 (3), 1294-1299, 2018 | 20 | 2018 |
| Discovery and Characterization of 1H-Pyrazol-5-yl-2-phenylacetamides as Novel, Non-Urea-Containing GIRK1/2 Potassium Channel Activators JM Wieting, AK Vadukoot, S Sharma, KK Abney, TM Bridges, JS Daniels, ... ACS chemical neuroscience 8 (9), 1873-1879, 2017 | 20 | 2017 |
| VU0810464, a non‐urea G protein‐gated inwardly rectifying K+ (Kir3/GIRK) channel activator, exhibits enhanced selectivity for neuronal Kir3 channels and … BN Vo, KK Abney, A Anderson, E Marron Fernandez de Velasco, ... British journal of pharmacology 176 (13), 2238-2249, 2019 | 11 | 2019 |
| Discovery, synthesis and characterization of a series of (1-alkyl-3-methyl-1H-pyrazol-5-yl)-2-(5-aryl-2H-tetrazol-2-yl) acetamides as novel GIRK1/2 potassium channel activators S Sharma, KA Kozek, KK Abney, S Kumar, N Gautam, Y Alnouti, ... Bioorganic & medicinal chemistry letters 29 (6), 791-796, 2019 | 8 | 2019 |
| Selective Activation of N,N′‐Diacyl Rhodamine Pro‐fluorophores Paired with Releasing Enzyme, Porcine Liver Esterase (PLE) KK Abney, SJ Ramos‐Hunter, IM Romaine, JS Goodwin, GA Sulikowski, ... Chemistry–A European Journal 24 (36), 8985-8988, 2018 | 6 | 2018 |
| Pro-fluorophore compounds and use thereof GA Sulikowski, KK Abney, SJ Ramos-Hunter, IM Romaine, CD Weaver US Patent 11,104,926, 2021 | | 2021 |
| Discovery and characterization of 1H-pyrazol-5-yl-2-phenylacetamides as novel, non-urea containing GIRK1/2 potassium channel activators S Sharma, J Wieting, A Vadukoot, K Abney, T Bridges, B Vo, A Andersone, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 254, 2017 | | 2017 |
